product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
LSD1 Antibody (1B2E5)
catalog :
NB100-1762
quantity :
0.1 ml (also 0.025 ml)
price :
409 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1B2E5
reactivity :
human, mouse
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, chromatin immunoprecipitation, immunohistochemistry - paraffin section
more info or order :
citations: 12
Reference
Antona A, Leo G, Favero F, Varalda M, Venetucci J, Faletti S, et al. Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation. Cell Death Discov. 2023;9:201 pubmed publisher
Haydn T, Kehr S, Willmann D, Metzger E, Schüle R, Fulda S. Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells. Int J Cancer. 2020;146:3435-3449 pubmed publisher
Kim D, Nam H, Lee W, Yim H, Ahn J, Park S, et al. PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response. Mol Cell. 2018;69:398-411.e6 pubmed publisher
Lobo J, Rodrigues A, Antunes L, Graça I, Ramalho Carvalho J, Vieira F, et al. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer. Urol Oncol. 2018;36:161.e7-161.e17 pubmed publisher
Pajtler K, Weingarten C, Thor T, Künkele A, Heukamp L, Buttner R, et al. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathol Commun. 2013;1:19 pubmed publisher
Kashyap V, Ahmad S, Nilsson E, Helczynski L, Kenna S, Persson J, et al. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol. 2013;7:555-66 pubmed publisher
Serce N, Gnatzy A, Steiner S, Lorenzen H, Kirfel J, Buettner R. Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin Pathol. 2012;12:13 pubmed publisher
Janzer A, Lim S, Fronhoffs F, Niazy N, Buettner R, Kirfel J. Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components. Biochem Biophys Res Commun. 2012;421:665-70 pubmed publisher
Bennani Baiti I, Machado I, Llombart Bosch A, Kovar H. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum Pathol. 2012;43:1300-7 pubmed publisher
Schildhaus H, Riegel R, Hartmann W, Steiner S, Wardelmann E, Merkelbach Bruse S, et al. Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum Pathol. 2011;42:1667-75 pubmed publisher
Kauffman E, Robinson B, Downes M, Powell L, Lee M, Scherr D, et al. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog. 2011;50:931-44 pubmed publisher
Lim S, Janzer A, Becker A, Zimmer A, Schüle R, Buettner R, et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis. 2010;31:512-20 pubmed publisher
product information
master code :
NB100-1762
SKU :
NB100-1762
product name :
LSD1 Antibody (1B2E5)
unit size :
0.1 ml (also 0.025 ml)
description :
The LSD1 Antibody (1B2E5) - BSA Free from Novus is a mouse monoclonal antibody to LSD1. This antibody reacts with human,mouse,primate. The LSD1 Antibody (1B2E5) - BSA Free has been validated for the following applications: Chemotaxis,IF/IHC,ELISA,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry,Simple Western,Chromatin Immunoprecipitation (ChIP),Knockdown Validated.
target :
LSD1
category :
Primary Antibodies
buffer :
Ascites
clonality :
Monoclonal
clone :
1B2E5
conjugate :
Unconjugated
host :
Mouse
immunogen :
Purified recombinant fragment of human LSD1 (between amino acids 400-600) expressed in E. coli. [UniProt# O60341]
isotype :
IgG1
purity :
Unpurified
species :
Human,Mouse,Primate
theoretical molecular weight :
93 kDa
gene symbol :
KDM1A
Antibody validation :
Knockout/Knockdown
accessionNumbers :
O60341
applications :
Chemotaxis,IF/IHC,ELISA,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry,Simple Western,Chromatin Immunoprecipitation (ChIP),Knockdown Validated
USD :
409 USD
alt names :
amine oxidase (flavin containing) domain 2, AOF2lysine-specific histone demethylase 1, BHC110FAD-binding protein BRAF35-HDAC complex, 110 kDa subunit, Flavin-containing amine oxidase domain-containing protein 2, KIAA0601KDM1, LSD1BRAF35-HDAC complex protein BHC110, lysine (K)-specific demethylase 1, lysine (K)-specific demethylase 1A, lysine-specific histone demethylase 1A
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.